National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.

NEWS

NEWSadmin2022-11-16T13:57:04-05:00

More Than 200 Patient Advocates, Healthcare Entities, Companies Urge Finalized Pharmacy DIR Fee Transparency Rule That Would Promote Patient Access, Protect Pharmacy Viability Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”
Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”.
March 11, 2022

Read Time: 1.6 min.
CDC Article Validates Families’ Reliance on Pharmacies During COVID, Need to Sustain Access
Especially for the most vulnerable Americans, the CDC article emphasized the critical importance of sustained pharmacy access.
March 11, 2022

Read Time: 2.3 min.
NACDS Releases Poll: 70% of Adults Back Extension of Policies Giving Access to Pharmacies’ Pandemic Services NACDS urges Biden Administration to ensure clarity or to act decisively to extend PREP Act authorities that have served Americans well, and that Americans do not want to see rolled back
NACDS urges Biden Administration to ensure clarity or to act decisively to extend PREP Act authorities that have served Americans well, and that Americans do not want to see rolled back.
March 11, 2022

Read Time: 4.6 min.
NACDS Expresses Support for CMS’ Pharmacy DIR Fee Transparency Proposal, Urges Additional Actions to Achieve Comprehensive Pharmacy DIR Reform, Protect Patients’ Access to Care NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.
NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.
March 7, 2022

Read Time: 3.7 min.
NACDS Statement on AMA Criticism of Pharmacy’s Role in COVID Antivirals
NACDS President and CEO Steven C. Anderson issued the following statement today following statements by the American Medical Association (AMA) regarding the Test to Treat Initiative for COVID antivirals that was mentioned by President Joe Biden and released by the Biden Administration last week.
March 7, 2022

Read Time: 2.7 min.
In Case You Missed It: Virginia Rep. Morgan Griffith Links Importance of Permanent Pharmacy Pandemic Flexibilities and Patient Access at House Subcommittee Hearing
On Wednesday, March 2, the Oversight and Investigations Subcommittee of the U.S. House of Representatives Energy and Commerce Committee held a hearing titled, “Lessons from the Frontline: COVID-19’s Impact on American Health Care.” 
March 4, 2022

Read Time: 2.7 min.
On Antivirals, Further Action Needed for Preparedness, Access, and Equity
During the State of the Union address on March 1, 2022, President Biden discussed the launch of the Test-to-Treat Iniative for COVID-19 antivirals.
March 3, 2022

Read Time: 1.9 min.
Former Defense Secretary Dr. Mark Esper to Address 2022 NACDS Annual Meeting
NACDS today announced that Dr. Mark Esper – the 27th U.S. Secretary of Defense – will speak during the Business Program on Tuesday, April 26, at the 2022 NACDS Annual Meeting, which will be hosted April 23-26 in Palm Beach, FL.
March 2, 2022

Read Time: 2.3 min.
NACDS: Pharmacies’ Trust, Access and Equity Inform Congress’ Response to COVID-19 U.S. House Energy and Commerce subcommittee to hold hearing on pandemic’s lessons
U.S. House Energy and Commerce subcommittee to hold hearing on pandemic’s lessons.
March 1, 2022

Read Time: 3.3 min.
NACDS Says 2022 Can Be the Year of the Pharmacy Voter NACDS RxIMPACT Votes begins a 36-week push to Election 2022
NACDS RxIMPACT Votes begins a 36-week push to Election 2022.
February 28, 2022

Read Time: 1.6 min.

NACDS represents traditional drug stores, supermarkets and mass merchants with pharmacies. Chains operate over 40,000 pharmacies, and NACDS’ member companies include regional chains, with a minimum of four stores, and national companies. Chains employ nearly 3 million individuals, including 155,000 pharmacists. They fill over 3 billion prescriptions yearly, and help patients use medicines correctly and safely, while offering innovative services that improve patient health and healthcare affordability. NACDS members also include more than 900 supplier partners and over 70 international members representing 21 countries.

© National Association of Chain Drug Stores | All Rights Reserved | Privacy & Disclaimer